Exploring Non-Pharmaceutical Neurology for Concussion and Vertigo Grand Rapids, Aruba - March 5, 2026 / North Lakes ...

Board Includes Former Fortune 100 Pharma Executive and Leading US Medical Research AcademicJericho, New York, March 05, 2026 (GLOBE NEWSWIRE) ...

Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain™U.S. prescription drugs market project to grow from $63 ...

Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 ...

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...

Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial initiation targeted for mid-2026. Company's Multi-Cytokine Platform enables selective cytokine targeting ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...

As AI drug discovery enters 2026, the industry faces a pivotal year of clinical tests, regulatory clarity, and market consolidation. Here, Dr Raminderpal Singh examines where AI is delivering ...